Real-time enrollment status for this early stage triple-negative breast carcinoma clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 11:02 AM UTC
| NCT Number | NCT06349642 |
| Recruiting Status | Recruiting |
| Condition | Early Stage Triple-Negative Breast Carcinoma |
| Phase | Clinical Trial |
| Target Enrollment | 324 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Mayo Clinic |
| Last Updated on CT.gov | March 12, 2026 (Mar 12, 2026) |
As of July 13, 2026: Clinical trial NCT06349642 is currently recruiting participants. This clinical trial study for early stage triple-negative breast carcinoma is actively seeking new participants at 3 locations across the United States. The study is sponsored by Mayo Clinic. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06349642 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06349642 was last updated Mar 12, 2026 (March 12, 2026). HelloStudys verifies this status automatically.